Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience

Importance: Passive antibody transfer is a longstanding treatment strategy for infectious diseases that involve the respiratory system. In this context, human convalescent plasma has been used to treat coronavirus disease 2019 (COVID-19), but the efficacy remains uncertain. Objective: To explore pot...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:medRxiv
Autori principali: Joyner, Michael J, Senefeld, Jonathon W, Klassen, Stephen A, Mills, John R, Johnson, Patrick W, Theel, Elitza S, Wiggins, Chad C, Bruno, Katelyn A, Klompas, Allan M, Lesser, Elizabeth R, Kunze, Katie L, Sexton, Matthew A, Diaz Soto, Juan C, Baker, Sarah E, Shepherd, John R.A., van Helmond, Noud, van Buskirk, Camille M, Winters, Jeffrey L, Stubbs, James R, Rea, Robert F, Hodge, David O, Herasevich, Vitaly, Whelan, Emily R, Clayburn, Andrew J, Larson, Kathryn F, Ripoll, Juan G, Andersen, Kylie J, Buras, Matthew R, Vogt, Matthew N.P., Dennis, Joshua J, Regimbal, Riley J, Bauer, Philippe R, Blair, Janis E, Paneth, Nigel S, Fairweather, DeLisa, Wright, R. Scott, Carter, Rickey E, Casadevall, Arturo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Cold Spring Harbor Laboratory 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7430623/
https://ncbi.nlm.nih.gov/pubmed/32817978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.08.12.20169359
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi